Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Efficacy Study of NEUROSTEM in Alzheimer's Disease
NCT04954534Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jul 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in Alzheimer's disease (AD), sponsored by Samsung Medical Center. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 24 weeks. Status: unknown.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04954534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954534.